PRESS RELEASE published on 02/15/2025 at 00:00, 9 months 18 days ago Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth Onco-Innovations Limited announces promising results in slowing colorectal cancer growth using nanoparticle PNKP Compound as standalone and combination treatment, targeting cancer cells precisely Colorectal Cancer Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Targeted Therapy
BRIEF published on 02/11/2025 at 01:05, 9 months 22 days ago Onco-Innovations Reveals Promising Results for Cancer Treatment Technology Cancer Treatment Colorectal Cancer Radiation Therapy Onco-Innovations PNKP Inhibitors
BRIEF published on 02/11/2025 at 01:05, 9 months 22 days ago Onco-Innovations révèle des résultats prometteurs en matière de technologie de traitement du cancer Cancer Colorectal Traitement Du Cancer Radiothérapie Innovations Oncologiques Inhibiteurs De La PNKP
PRESS RELEASE published on 02/11/2025 at 01:00, 9 months 22 days ago Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments Colorectal Cancer Radiation Therapy PNKP Inhibitors Onco-Innovations Limited Cancer Cells
BRIEF published on 02/07/2025 at 01:35, 9 months 26 days ago Onco-Innovations Explores AI-Driven Collaboration with Quantify Research Cancer Treatment AI-driven Analytics Real-world Data Onco-Innovations Quantify Research
BRIEF published on 02/07/2025 at 01:35, 9 months 26 days ago Onco-Innovations explore la collaboration basée sur l'IA avec Quantify Research Données Du Monde Réel Traitement Du Cancer Analyses Basées Sur L'IA Innovations Oncologiques Quantifier La Recherche
PRESS RELEASE published on 02/07/2025 at 01:30, 9 months 26 days ago Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research Oncology Research Healthcare Data Analytics Onco-Innovations Quantify Research EOI
BRIEF published on 02/04/2025 at 05:41, 10 months 1 day ago Onco-Innovations Acquires Inka Health to Boost Cancer Research with AI Acquisition Innovation AI Technology Oncology Cancer Research
BRIEF published on 02/04/2025 at 05:41, 10 months 1 day ago Onco-Innovations acquiert Inka Health pour stimuler la recherche sur le cancer grâce à l'IA Acquisition Innovation Oncologie Technologie De L'IA Recherche Sur Le Cancer
PRESS RELEASE published on 02/04/2025 at 05:36, 10 months 1 day ago Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities Acquisition AI Technology Precision Oncology Onco-Innovations Inka Health
Published on 12/05/2025 at 21:00, 15 minutes ago The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 50 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 1 hour ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 25 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 55 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:58, 2 hours 17 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 59 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 28 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 57 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 57 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 4 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 4 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 16 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE